BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23253474)

  • 1. The systems containing clays and clay minerals from modified drug release: a review.
    Rodrigues LA; Figueiras A; Veiga F; de Freitas RM; Nunes LC; da Silva Filho EC; da Silva Leite CM
    Colloids Surf B Biointerfaces; 2013 Mar; 103():642-51. PubMed ID: 23253474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological evaluation of clay minerals and derived nanocomposites: a review.
    Maisanaba S; Pichardo S; Puerto M; Gutiérrez-Praena D; Cameán AM; Jos A
    Environ Res; 2015 Apr; 138():233-54. PubMed ID: 25732897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clay and Polymer-Based Composites Applied to Drug Release: A Scientific and Technological Prospection.
    Meirelles LMA; Raffin FN
    J Pharm Pharm Sci; 2017; 20(0):115-134. PubMed ID: 28554346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clay minerals: Properties and applications to dermocosmetic products and perspectives of natural raw materials for therapeutic purposes-A review.
    Moraes JDD; Bertolino SRA; Cuffini SL; Ducart DF; Bretzke PE; Leonardi GR
    Int J Pharm; 2017 Dec; 534(1-2):213-219. PubMed ID: 29038067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer-clay nanocomposites as precursors of nanostructured carbon materials for electrochemical devices: templating effect of clays.
    Fernández-Saavedra R; Darder M; Gómez-Avilés A; Aranda P; Ruiz-Hitzky E
    J Nanosci Nanotechnol; 2008 Apr; 8(4):1741-50. PubMed ID: 18572573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method to improve the clarity and rheological properties of polymer/clay nanocomposites by using fractionated clay particles.
    Cipriano BH; Kashiwagi T; Zhang X; Raghavan SR
    ACS Appl Mater Interfaces; 2009 Jan; 1(1):130-5. PubMed ID: 20355764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrous Clays in Dermopharmaceutical and Cosmetic Applications: Traditional and Emerging Perspectives.
    Cao L; Xie W; Cui H; Xiong Z; Tang Y; Zhang X; Feng Y
    Int J Pharm; 2022 Sep; 625():122097. PubMed ID: 35952800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folk pharmaceutical formulations in western Mediterranean: identification and safety of clays used in pelotherapy.
    Sánchez-Espejo R; Aguzzi C; Cerezo P; Salcedo I; López-Galindo A; Viseras C
    J Ethnopharmacol; 2014 Aug; 155(1):810-4. PubMed ID: 24960182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of clay minerals with microorganisms: a review of experimental data].
    Naĭmark EB; Eroshchev-Shak VA; Chizhikova NP; Kompantseva EI
    Zh Obshch Biol; 2009; 70(2):155-67. PubMed ID: 19425352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clay-based polymer nanocomposites: research and commercial development.
    Zeng QH; Yu AB; Lu GQ; Paul DR
    J Nanosci Nanotechnol; 2005 Oct; 5(10):1574-92. PubMed ID: 16245517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coating of silica sand with aluminosilicate clay.
    Jerez J; Flury M; Shang J; Deng Y
    J Colloid Interface Sci; 2006 Feb; 294(1):155-64. PubMed ID: 16085082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modification of clay minerals for the adsorption of herbicides widely used in olive groves.
    Celis R; Trigo C; Facenda G; Hermosín Mdel C; Cornejo J
    J Agric Food Chem; 2007 Aug; 55(16):6650-8. PubMed ID: 17628074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of rhodamine 6G with different types of clay minerals.
    Li Z; Potter N; Rasmussen J; Weng J; Lv G
    Chemosphere; 2018 Jul; 202():127-135. PubMed ID: 29567610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBAT based nanocomposites for medical and industrial applications.
    Fukushima K; Wu MH; Bocchini S; Rasyida A; Yang MC
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1331-51. PubMed ID: 24364930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clay-fulleropyrrolidine nanocomposites.
    Gournis D; Jankovic L; Maccallini E; Benne D; Rudolf P; Colomer JF; Sooambar C; Georgakilas V; Prato M; Fanti M; Zerbetto F; Sarova GH; Guldi DM
    J Am Chem Soc; 2006 May; 128(18):6154-63. PubMed ID: 16669685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From edible clay to a clay-containing formulation for optimization of oral delivery of some trace elements: a review.
    Kikouama OJ; Balde L
    Int J Food Sci Nutr; 2010 Dec; 61(8):803-22. PubMed ID: 20528584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of clay mineral structure and surfactant nature on the adsorption capacity of surfactants by clays.
    Sánchez-Martín MJ; Dorado MC; del Hoyo C; Rodríguez-Cruz MS
    J Hazard Mater; 2008 Jan; 150(1):115-23. PubMed ID: 17532126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desorption of arsenic from clay and humic acid-coated clay by dissolved phosphate and silicate.
    Sharma P; Kappler A
    J Contam Hydrol; 2011 Nov; 126(3-4):216-25. PubMed ID: 22115087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sol-gel network silica/modified montmorillonite clay hybrid nanocomposites for hydrophobic surface coatings.
    Meera KM; Sankar RM; Murali A; Jaisankar SN; Mandal AB
    Colloids Surf B Biointerfaces; 2012 Feb; 90():204-10. PubMed ID: 22056084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending surfactant-modified 2:1 clay minerals for the uptake and removal of diclofenac from water.
    Sun K; Shi Y; Chen H; Wang X; Li Z
    J Hazard Mater; 2017 Feb; 323(Pt A):567-574. PubMed ID: 27236838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.